國立高雄大學圖資館 |

語系: 繁體中文

說明(常見問題)

圖資館首頁

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Antimicrobial drug resistance.Volume...

Mayers, Douglas L.

Antimicrobial drug resistance.Volume 2,Clinical and epidemiological aspects

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Antimicrobial drug resistance.edited by Douglas L. Mayers ... [et al.].
其他題名:	Clinical and epidemiological aspects
其他作者:	Mayers, Douglas L.
出版者:	Cham :Springer International Publishing :2017.
面頁冊數:	xxi, 855 p. :ill., digital ;24 cm.
Contained By:	Springer eBooks
標題:	Drug resistance in microorganisms.
電子資源:	http://dx.doi.org/10.1007/978-3-319-47266-9
ISBN:	9783319472669$q(electronic bk.)

Antimicrobial drug resistance.Volume 2,Clinical and epidemiological aspects
Antimicrobial drug resistance.Volume 2,Clinical and epidemiological aspects[electronic resource] /Clinical and epidemiological aspectsedited by Douglas L. Mayers ... [et al.]. - 2nd ed. - Cham :Springer International Publishing :2017. - xxi, 855 p. :ill., digital ;24 cm.

History of Drug-Resistant Microbes -- Evolutionary Biology of Drug Resistance -- Pharmacology of Drug Resistance -- Drug Development for Drug-Resistant Pathogens -- Genetic Mechanisms of Transfer of Drug Resistance -- Mutations as a Basis of Antimicrobial Resistance -- Altered Drug Targets -- Enzymatic Modification of Drugs -- Reduced Drug Penetration -- Active Efflux Mechanism -- Biofilms -- Beta-Lactamases -- Penicillin Binding Proteins -- Aminoglycosides -- Tetracyclines and ChloramphenicolQuinolones -- Plasmid Mediated Quinolone Resistance to Macrolides, Lincosamides, and Streptogramins -- Mechanisms of Resistance in Metronidazole -- Glycopeptide-resistance in eneterococci -- Daptomycin Resistance -- Oxazolidinones -- PolymyxinsSulfonamides and Trimethoprim -- Antimycobacterial Agents -- Amphotericin (Polyenes) -- Azoles -- Flucytosine -- Echinocandins -- Antifungal Targets, Mechanisms of Action, and Resistance in Candida albicans -- Herpes Nucleoside Drugs -- Influenza Drugs -- HIV Nucleoside Drugs -- HIV Non-Nucleoside Drugs -- HIV Protease Inhibitors -- HIV Entry Inhibitors -- HIV Integrase Inhibitors -- Hepatitis B -- Hepatitis C -- Agents for anaerobic protozoa -- Antimalarial Agents -- Agents for Leishmania -- Agents for Trypanosomes -- Agents for Toxoplasma -- Agents for Cryptosporidium -- Agents against Nematodes -- Agents against Trematodes and Cestodes -- Agents against Ectoparasites.

The two volumes included in Antimicrobial Drug Resistance, Second Edition is an updated, comprehensive and multidisciplinary reference covering the area of antimicrobial drug resistance in bacteria, fungi, viruses, and parasites from basic science, clinical, and epidemiological perspectives. This newly revised compendium reviews the most current research and development on drug resistance while still providing the information in the accessible format of the first edition. The first volume, Antimicrobial Drug Resistance: Mechanisms of Drug Resistance, is dedicated to the biological basis of drug resistance and effective avenues for drug development. With the emergence of more drug-resistant organisms, the approach to dealing with the drug resistance problem must include the research of different aspects of the mechanisms of bacterial resistance and the dissemination of resistance genes as well as research utilizing new genomic information. These approaches will permit the design of novel strategies to develop new antibiotics and preserve the effectiveness of those currently available. The second volume, Antimicrobial Drug Resistance: Clinical and Epidemiological Aspects, is devoted to the clinical aspects of drug resistance. Although there is evidence that restricted use of a specific antibiotic can be followed by a decrease in drug resistance to that agent, drug resistance control is not easily achieved. Thus, the infectious diseases physician requires input from the clinical microbiologist, antimicrobial stewardship personnel, and infection control specialist to make informed choices for the effective management of various strains of drug-resistant pathogens in individual patients. This 2-volume set is an important reference for students in microbiology, infectious diseases physicians, medical students, basic scientists, drug development researchers, microbiologists, epidemiologists, and public health practitioners.

ISBN: 9783319472669$q(electronic bk.)

Standard No.: 10.1007/978-3-319-47266-9doiSubjects--Topical Terms:

192960
Drug resistance in microorganisms.

LC Class. No.: QR177

Dewey Class. No.: 616.9041

Antimicrobial drug resistance.Volume 2,Clinical and epidemiological aspects
LDR:04431nmm a2200337 a 4500 001 517496
003 DE-He213
005 20170620223451.0
006 m d
007 cr nn 008maaau
008 180316s2017 gw s 0 eng d
020 $a 9783319472669$q(electronic bk.)
020 $a 9783319472645$q(paper)
024 7 $a 10.1007/978-3-319-47266-9 $2 doi
035 $a 978-3-319-47266-9
040 $a GP $c GP
041 0 $a eng
050 4 $a QR177
072 7 $a MMG $2 bicssc
072 7 $a MED071000 $2 bisacsh
082 0 4 $a 616.9041 $2 23
090 $a QR177 $b .A631 2017
245 0 0 $a Antimicrobial drug resistance. $n Volume 2, $p Clinical and epidemiological aspects $h [electronic resource] / $c edited by Douglas L. Mayers ... [et al.].
246 3 0 $a Clinical and epidemiological aspects
250 $a 2nd ed.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2017.
300 $a xxi, 855 p. : $b ill., digital ; $c 24 cm.
505 0 $a History of Drug-Resistant Microbes -- Evolutionary Biology of Drug Resistance -- Pharmacology of Drug Resistance -- Drug Development for Drug-Resistant Pathogens -- Genetic Mechanisms of Transfer of Drug Resistance -- Mutations as a Basis of Antimicrobial Resistance -- Altered Drug Targets -- Enzymatic Modification of Drugs -- Reduced Drug Penetration -- Active Efflux Mechanism -- Biofilms -- Beta-Lactamases -- Penicillin Binding Proteins -- Aminoglycosides -- Tetracyclines and ChloramphenicolQuinolones -- Plasmid Mediated Quinolone Resistance to Macrolides, Lincosamides, and Streptogramins -- Mechanisms of Resistance in Metronidazole -- Glycopeptide-resistance in eneterococci -- Daptomycin Resistance -- Oxazolidinones -- PolymyxinsSulfonamides and Trimethoprim -- Antimycobacterial Agents -- Amphotericin (Polyenes) -- Azoles -- Flucytosine -- Echinocandins -- Antifungal Targets, Mechanisms of Action, and Resistance in Candida albicans -- Herpes Nucleoside Drugs -- Influenza Drugs -- HIV Nucleoside Drugs -- HIV Non-Nucleoside Drugs -- HIV Protease Inhibitors -- HIV Entry Inhibitors -- HIV Integrase Inhibitors -- Hepatitis B -- Hepatitis C -- Agents for anaerobic protozoa -- Antimalarial Agents -- Agents for Leishmania -- Agents for Trypanosomes -- Agents for Toxoplasma -- Agents for Cryptosporidium -- Agents against Nematodes -- Agents against Trematodes and Cestodes -- Agents against Ectoparasites.
520 $a The two volumes included in Antimicrobial Drug Resistance, Second Edition is an updated, comprehensive and multidisciplinary reference covering the area of antimicrobial drug resistance in bacteria, fungi, viruses, and parasites from basic science, clinical, and epidemiological perspectives. This newly revised compendium reviews the most current research and development on drug resistance while still providing the information in the accessible format of the first edition. The first volume, Antimicrobial Drug Resistance: Mechanisms of Drug Resistance, is dedicated to the biological basis of drug resistance and effective avenues for drug development. With the emergence of more drug-resistant organisms, the approach to dealing with the drug resistance problem must include the research of different aspects of the mechanisms of bacterial resistance and the dissemination of resistance genes as well as research utilizing new genomic information. These approaches will permit the design of novel strategies to develop new antibiotics and preserve the effectiveness of those currently available. The second volume, Antimicrobial Drug Resistance: Clinical and Epidemiological Aspects, is devoted to the clinical aspects of drug resistance. Although there is evidence that restricted use of a specific antibiotic can be followed by a decrease in drug resistance to that agent, drug resistance control is not easily achieved. Thus, the infectious diseases physician requires input from the clinical microbiologist, antimicrobial stewardship personnel, and infection control specialist to make informed choices for the effective management of various strains of drug-resistant pathogens in individual patients. This 2-volume set is an important reference for students in microbiology, infectious diseases physicians, medical students, basic scientists, drug development researchers, microbiologists, epidemiologists, and public health practitioners.
650 0 $a Drug resistance in microorganisms. $3 192960
650 0 $a Anti-infective agents. $3 204538
650 1 4 $a Biomedicine. $3 273648
650 2 4 $a Drug Resistance. $3 338425
650 2 4 $a Infectious Diseases. $3 274275
700 1 $a Mayers, Douglas L. $3 375821
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer eBooks
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-47266-9
950 $a Biomedical and Life Sciences (Springer-11642)